Global POC Infectious Diseases Market 2015-2019

1 Executive Summary
2 List of Abbreviations
3 Scope of the Report
3.1 Market overview
3.2 Product offerings
4 Market Research Methodology
4.1 Market research process
4.2 Research methodology
5 Introduction
6 Overview
7 Hospital-acquired Infections
8 Homecare Testing
8.1 Overview
8.2 Types of homecare
9 Market Landscape
9.1 Market overview
9.2 Market size and forecast
9.3 Five forces analysis
10 Market Segmentation by Diseases
10.1.1 RSV
10.1.2 Flu
10.1.3 Adenovirus
10.1.4 Malaria
10.1.5 Strep B
10.1.6 Tuberculosis
10.1.7 Fecal occult blood
10.1.8 HIV
10.1.9 Infectious mononucleosis
11 Geographical Segmentation
11.1 POC infectious diseases market in Americas
11.1.1 Market size and forecast
11.2 POC infectious diseases market in EMEA
11.2.1 Market size and forecast
11.3 POC infectious diseases market in APAC
11.3.1 Market size and forecast
12 Buying Criteria
13 Market Growth Drivers
14 Drivers and their Impact
15 Market Challenges
16 Impact of Drivers and Challenges
17 Market Trends
18 Trends and their Impact
19 Vendor Landscape
19.1 Competitive scenario
19.1.1 Key news
19.1.2 Mergers and acquisitions
19.2 Market share analysis 2014
19.3 Other prominent vendors
20 Key Vendor Analysis
20.1 Alere
20.1.1 Key facts
20.1.2 Business overview
20.1.3 Business segmentation by revenue 2013
20.1.4 Business segmentation by revenue 2012 and 2013
20.1.5 Geographical segmentation by revenue 2013
20.1.6 Business strategy
20.1.7 Recent developments
20.1.8 SWOT analysis
20.2 Meridian
20.2.1 Key facts
20.2.2 Business overview
20.2.3 Business segmentation by revenue 2014
20.2.4 Business segmentation by revenue 2013 and 2014
20.2.5 Geographical segmentation by revenue 2014
20.2.6 Business strategy
20.2.7 Recent developments
20.2.8 SWOT analysis
20.3 OraSure
20.3.1 Key facts
20.3.2 Business overview
20.3.3 Product segmentation
20.3.4 Business segmentation by revenue 2014
20.3.5 Business segmentation by revenue 2013 and 2014
20.3.6 Geographical segmentation by revenue 2014
20.3.7 Business strategy
20.3.8 Recent developments
20.3.9 SWOT analysis
20.4 Trinity Biotech
20.4.1 Key facts
20.4.2 Business overview
20.4.3 Business segmentation by revenue 2013
20.4.4 Business segmentation by revenue 2012 and 2013
20.4.5 Geographical segmentation by revenue 2013
20.4.6 Business strategy
20.4.7 Recent developments
20.4.8 SWOT analysis
21 Other Reports in this Series